Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Latorzeff

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 10, 2018
Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendationsJ Langrand-Escure, R de Crevoisier, C Llagostera, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 15, 2020
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]I Latorzeff, P Sargos, G Créhange, et al.
Neuro-Chirurgie|August 17, 2010
[Dosimetric stereotactic radiosurgical accident: Study of 33 patients treated for brain metastases]P-Y Borius, B Debono, I Latorzeff, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 12, 2023
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancerI Latorzeff, A Camps-Maléa, S Supiot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 4, 2020
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology groupY Belkacemi, I Latorzeff, A Hasbini, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 12, 2024
[Informed consent in radiotherapy care]C Sire, A Ducteil, J-L Lagrange, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 7, 2012
[Prospective economic evaluation of image-guided radiation therapy for prostate cancer in the framework of the national programme for innovative and costly therapies assessment]P Pommier, M Morelle, L Perrier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 21, 2014
[Impact of dynamic IMRT and tomotherapy in pelvic cancers: a prospective dosimetric study with 51 patients]S Servagi-Vernat, P Giraud, P Fenoglietto, et al.
Clinical and Translational Radiation Oncology|September 2, 2022
Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi surveyF Vilotte, D Pasquier, P Blanchard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 27, 2018
[Siriade 2.0: An e-learning platform for radiation oncology contouring]J-E Bibault, F Denis, A Roué, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 10, 2018
Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendationsJ Langrand-Escure, R de Crevoisier, C Llagostera, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 15, 2020
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]I Latorzeff, P Sargos, G Créhange, et al.
Neuro-Chirurgie|August 17, 2010
[Dosimetric stereotactic radiosurgical accident: Study of 33 patients treated for brain metastases]P-Y Borius, B Debono, I Latorzeff, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 12, 2023
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancerI Latorzeff, A Camps-Maléa, S Supiot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 4, 2020
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology groupY Belkacemi, I Latorzeff, A Hasbini, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 12, 2024
[Informed consent in radiotherapy care]C Sire, A Ducteil, J-L Lagrange, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 7, 2012
[Prospective economic evaluation of image-guided radiation therapy for prostate cancer in the framework of the national programme for innovative and costly therapies assessment]P Pommier, M Morelle, L Perrier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 21, 2014
[Impact of dynamic IMRT and tomotherapy in pelvic cancers: a prospective dosimetric study with 51 patients]S Servagi-Vernat, P Giraud, P Fenoglietto, et al.
Clinical and Translational Radiation Oncology|September 2, 2022
Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi surveyF Vilotte, D Pasquier, P Blanchard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 27, 2018
[Siriade 2.0: An e-learning platform for radiation oncology contouring]J-E Bibault, F Denis, A Roué, et al.
Pageof 8